Scarica l'app Stockscreener
67.85
1.84%
-1.27
Dopo l'orario di chiusura:
67.85
Precedente Chiudi:
$69.12
Aprire:
$67.87
Volume 24 ore:
955.02K
Relative Volume:
0.54
Capitalizzazione di mercato:
$6.07B
Reddito:
$288.07M
Utile/perdita netta:
$22.31M
Rapporto P/E:
479.17
EPS:
0.1416
Flusso di cassa netto:
$41.15M
1 W Prestazione:
-1.14%
1M Prestazione:
-25.46%
6M Prestazione:
+74.74%
1 anno Prestazione:
+148.63%
Intervallo 1D:
$66.62
$68.35
Intervallo di 1 settimana:
$66.62
$69.47
Portata 52W:
$21.14
$93.61
Liquidia Corp Stock (LQDA) Company Profile
Nome
Liquidia Corp
Settore
Telefono
919.328.4400
Indirizzo
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
67.85 | 6.19B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-15 | Ripresa | Jefferies | Buy |
| 2025-05-19 | Downgrade | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Iniziato | Raymond James | Outperform |
| 2024-06-25 | Iniziato | Oppenheimer | Perform |
| 2024-01-05 | Reiterato | Needham | Buy |
| 2022-09-19 | Ripresa | Wedbush | Underperform |
| 2022-09-01 | Downgrade | Wedbush | Neutral → Underperform |
| 2022-07-22 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-05-31 | Iniziato | BTIG Research | Buy |
| 2022-05-26 | Iniziato | BofA Securities | Buy |
| 2020-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-11-08 | Ripresa | Jefferies | Buy |
| 2018-09-05 | Iniziato | Wedbush | Outperform |
| 2018-08-20 | Iniziato | Jefferies | Buy |
| 2018-08-20 | Iniziato | Needham | Buy |
Mostra tutto
Liquidia Corp Borsa (LQDA) Ultime notizie
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio? - Yahoo Finance
What Could Put Liquidia (NASDAQ:LQDA) On A New Path? - Kalkine Media
LQDA - Finviz
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen - ChartMill
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India
Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - marketbeat.com
Liquidia Corp Stock Intrinsic Values - GuruFocus
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - marketbeat.com
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - marketbeat.com
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Two lung-disease studies will be presented in Barcelona - Stock Titan
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
Liquidia Corp Stock Operating Data - GuruFocus
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition? - Yahoo Finance
Q1 2025 Liquidia Corp Earnings Call Transcript - GuruFocus
Liquidia Corp (HAM:LT4) Valuation: Possible Value Trap, Think Twice - GuruFocus
Liquidia Corp (HAM:LT4)Valuation Measures & Financial Statistics - GuruFocus
HAM:LT4 Dividend: Does Liquidia Corp Pay a Dividend? - GuruFocus
Who's Buying or Selling Liquidia Corp (HAM:LT4) Stock Today? - GuruFocus
Liquidia Corp (HAM:LT4) Stock Price & 30 Year Financial Data - GuruFocus
Liquidia Corp (HAM:LT4) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Liquidia Corp (HAM:LT4) Competitors 2026 - GuruFocus
Bank of New York Mellon Corp Makes New Investment in Liquidia Corporation $LQDA - marketbeat.com
Liquidia Corp (LQDA) Stock Down 3.1% -- Now Undervalued? GF Scor - GuruFocus
Liquidia Corporation $LQDA Shares Bought by Seven Fleet Capital Management LP - MarketBeat
Liquidia Slips as Post-Earnings Selling Continues - Quiver Quantitative
Liquidia (NASDAQ:LQDA) Director Katherine Rielly-Gauvin Sells 36,789 Shares of Stock - MarketBeat
Insider at Liquidia (NASDAQ: LQDA) plans multimillion-dollar stock sale - Stock Titan
Liquidia (NASDAQ: LQDA) director sells 55K shares in 10b5-1 trades - Stock Titan
Liquidia Corp (LQDA) Shares Fall 5.8% -- What GF Score of 70 Tel - GuruFocus
Liquidia Corp (LQDA) CMO cashes in options, unloads 79K+ shares - Stock Titan
Liquidia (NASDAQ: LQDA) director to sell shares after option exercises - Stock Titan
Liquidia (NASDAQ: LQDA) officer eyes $3.7M Rule 144 stock resale - Stock Titan
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion? - Zacks Investment Research
Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA - MarketBeat
A Look at Liquidia Corp (LQDA) After 4.3% Gain -- GF Value $267. - GuruFocus
Liquidia (NASDAQ: LQDA) affiliate plans new stock sale after $710K July trade - Stock Titan
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now? - Yahoo Finance
Greenhaven Road Capital: Short Term Gain Realized from Liquidia (LQDA), Investment to Be Revisited - Yahoo Finance
Liquidia Corp Azioni (LQDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):